Skip to search boxSkip to navigationSkip to main content

Current therapy of Wilms' tumor

  • Arthur M Smith
    ,
  • J. Priestley
    ,
  • P. Tomashefsky
    ,
  • M. Tannenbaum
    ,
  • J. Lattimer
Scholary Output:
Contribution to journal
Article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Whereas as recently as ten years ago most children with Wilms' tumor died, today even children initially presenting with symptoms and signs of advanced metastatic disease have a chance for survival. Basic studies on a naturally occurring tumor in rats, which is quite similar to human Wilms' tumor both morphologically and pathophysiologically, have demonstrated the clear cut therapeutic advantage of the combination of actinomycin D and irradiation on this disease process. These results can be directly translated into the success story that has been seen in the clinical management of human Wilms' tumor. Further research remains to be done concerning the immunologic aspects of Wilms' tumor activity.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1652-1656 (5 pages)

Journal (Volume, Issue Number)

New York State Journal of Medicine (Volume 73, Issue 12)

Publication milestones

  • Published - 12/01/1973

Publication status

Published - 12/01/1973

ISSN

0028-7628

Publication IDs

  • Scopus: 0015876352
  • PubMed: 4350908

Publication metrics

Metrics

Fractional count
1
Fractional count
0.20
Fractional count
4
Fractional count
0.80
Fractional count
1
Fractional count
1
Scopus
citations

PlumX

Citation count
1